Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Oxybutynin Chloride in Managing Hot Flashes

ClinicalTrials.gov ID: NCT02961790

Public ClinicalTrials.gov record NCT02961790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 12:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-Blind, Controlled Trial of Oxybutynin in the Management of Hot Flashes

Study identification

NCT ID
NCT02961790
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Academic and Community Cancer Research United
Other
Enrollment
150 participants

Conditions and interventions

Interventions

  • Oxybutynin Chloride Drug
  • Placebo Other
  • Quality-of-Life Assessment Other
  • Questionnaire Administration Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2016
Primary completion
Apr 26, 2018
Completion
Apr 26, 2018
Last update posted
Jan 17, 2020

2016 – 2018

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Illinois CancerCare-Peoria Peoria Illinois 61615
Carle Cancer Center NCI Community Oncology Research Program Urbana Illinois 61801
Oncology Associates at Mercy Medical Center Cedar Rapids Iowa 52403
Cancer Center of Kansas - Wichita Wichita Kansas 67214
Saint Elizabeth Medical Center South Edgewood Kentucky 41017
Michigan Cancer Research Consortium NCORP Ann Arbor Michigan 48106
Mayo Clinic Rochester Minnesota 55905
Waverly Hematology Oncology Cary North Carolina 27518
AnMed Health Cancer Center Anderson South Carolina 29621
Rapid City Regional Hospital Rapid City South Dakota 57701
Saint Vincent Hospital -Green Bay Green Bay Wisconsin 54301
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792
Marshfield Clinic Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02961790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2020 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02961790 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →